Symbiotec Pharmalab IPO
Anticipated IPO. Symbiotec Pharmalabhas filed for an IPO but the dates, price band and lot size are not yet announced. The details below are from the company’s SEBI filing. This page updates automatically once the IPO is scheduled.
About Symbiotec Pharmalab
Symbiotec Pharmalab (Symbiotec Pharmalab Ltd.) is a pharmaceuticals company. It filed its draft red herring prospectus (DRHP) with SEBI on 19-Dec-2025, and received SEBI observations (approval) on 25-Mar-2026. The proposed IPO (fresh capital cum ofs) is expected to list on BSE and NSE. JM Financial is acting as a lead manager. IPO dates, price band and lot size have not been announced yet — this page updates automatically once they are.
IPO timeline
- DRHP filed with SEBI19 Dec 2025
- SEBI approval (observations)25 Mar 2026
- IPO dates & price bandTo be announced
- Open for subscriptionTo be announced
Sourced from the company’s draft offer document filed with SEBI. An IPO filing is not a guarantee that the issue will open, or of its timing — companies can amend or withdraw. Nothing here is investment advice.